ANDISSO T1200 PRO 12-Position Automated Transdermal Diffusion System
| Brand | ANDISSO |
|---|---|
| Origin | Shanghai, China |
| Manufacturer Type | Authorized Distributor |
| Country of Origin | China |
| Model | T1200 PRO |
| Pricing | Available Upon Request |
Overview
The ANDISSO T1200 PRO is a precision-engineered 12-position automated transdermal diffusion system designed for in vitro release testing (IVRT) and in vitro permeation testing (IVPT) of topical pharmaceuticals and dermocosmetic formulations. It operates on the Franz diffusion cell principle—a standardized hydrodynamic configuration widely adopted in regulatory science for modeling percutaneous drug transport across biological or synthetic membranes. The system complies fully with United States Pharmacopeia Chapter <1724> “Transdermal Delivery Systems—In Vitro Release Testing” and supports method development aligned with ICH Q5C, Q6A, and ISO 10993-10 biocompatibility assessment frameworks. Its core architecture integrates dry-heating temperature control modules and modified Franz cells with optimized donor-receptor geometry, ensuring stable thermal equilibrium (±0.2 °C), minimal evaporation loss, and high reproducibility across parallel runs—critical for comparative formulation screening and stability-indicating assay validation.
Key Features
- 12 independent diffusion stations with synchronized temperature regulation via Peltier-based dry-heating modules—eliminating water bath contamination risks and enabling precise setpoint control from 25 °C to 40 °C (±0.2 °C accuracy)
- Modular Franz cell design featuring standardized 1.5–3.0 cm² effective diffusion area, removable donor chambers with septum-sealed ports, and receptor volumes configurable between 2.5 mL and 7.0 mL
- Automated sampling capability with programmable time points (up to 24 intervals per run), integrated syringe pumps, and fraction collector compatibility for unattended operation over 72+ hours
- Stainless-steel and borosilicate glass construction compliant with USP <1724> material specifications; all wetted parts meet USP Class VI biocompatibility requirements
- Real-time monitoring interface displaying temperature, sampling timestamps, agitation speed (optional magnetic stirring at 200–600 rpm), and system status alerts
Sample Compatibility & Compliance
The T1200 PRO accommodates a broad range of sample formats including semisolid gels, creams, ointments, emulsions, transdermal patches (matrix and reservoir types), and cosmetic actives such as retinoids, niacinamide, and peptide complexes. Membrane options include human epidermis (fresh/frozen), porcine ear skin, Strat-M® synthetic membranes, and silicone elastomer controls—each validated per ASTM E2874 and ISO 10993-10 protocols. All operational parameters—including diffusion area, receptor medium composition (e.g., PBS pH 7.4 ± 0.2, ethanol/water mixtures), and sampling volume (50–500 µL) —are fully configurable to meet compendial and internal SOP requirements. The system supports audit-ready documentation workflows compliant with FDA 21 CFR Part 11 (when paired with validated LIMS or electronic lab notebook integration) and GLP/GMP environments requiring full traceability of calibration, maintenance, and test execution records.
Software & Data Management
The embedded control software provides intuitive scheduling of multi-step protocols, real-time deviation logging, and export of raw time-series concentration data in CSV and Excel-compatible formats. Optional PC-based software extends functionality with statistical process control (SPC) charts, coefficient of variation (CV%) calculation per time point, and automated IVRT/IVPT profile comparison using model-independent metrics (e.g., similarity factor f₂, dissolution efficiency DE₆₀). Audit trails record user actions, parameter changes, and system events with tamper-proof timestamps—essential for regulatory submissions under EMA CHMP/Q5C and PMDA guidance. Data integrity safeguards include role-based access control, electronic signatures, and secure local storage with optional cloud backup (validated per ISO/IEC 27001).
Applications
- Comparative IVRT profiling of generic vs. reference listed drug (RLD) transdermal products per FDA draft guidance (2022)
- Early-stage formulation optimization for sustained-release topical delivery systems
- Stability-indicating release testing under accelerated and long-term storage conditions
- Skin irritation and sensitization potential assessment via permeation kinetics of preservatives and surfactants
- Regulatory dossier preparation for ANDA, NDA, and MAA submissions requiring USP <1724>-compliant datasets
- Method transfer and verification across QC laboratories in global manufacturing networks
FAQ
Does the T1200 PRO support both IVRT and IVPT protocols?
Yes—the system is configured to execute either test type by adjusting membrane selection, receptor medium composition, and sampling frequency in accordance with USP <1724> and ICH guidelines.
Can the system be integrated with HPLC or LC-MS analytical workflows?
Absolutely—fraction collector outputs are compatible with autosampler vials (e.g., 1.5 mL conical or 2 mL screw-top), and timing synchronization ensures alignment with chromatographic run schedules.
Is calibration verification documented per ISO/IEC 17025 requirements?
Calibration certificates for temperature sensors, volume dispensers, and timing modules are provided upon installation; users may perform routine checks using NIST-traceable references per internal SOP.
What maintenance is required for long-term operational reliability?
Routine cleaning of diffusion cells and tubing with IPA/water rinses is recommended after each study; annual preventive maintenance includes sensor recalibration, pump performance validation, and firmware updates.
Is technical support available outside mainland China?
ANDISSO provides remote diagnostics and application engineering support globally through authorized regional partners, with English-language documentation and video SOP libraries included standard.
